Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated review finds. This is a shift from the previous version of the review, which did not find sufficient evidence that screening reduced prostate cancer deaths. The update appears in the Cochrane Database of Systematic Reviews.

AI summaries can be wrong sometimes—always verify important details using the source link below.